^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MSIntuit™ CRC

Company:
Owkin
Type:
CE Marked
Related tests:

Details

Evidence
MSIntuit™ CRC is a CE-marked AI diagnostic that optimizes MSI testing for colorectal cancer through a prescreening approach with digital H&E slides. Suitable for adults with primary colorectal cancer. Sensitivity is on par with the highest current standards of MSI screening. MSIntuit CRC is 95% sensitive and 46% specific, enabling an early rule-out of 40% of cases.
Cancer:
Colorectal Cancer
Gene:
MSI (Microsatellite instability)
Approvals
Date
Cancer
Gene
Drug
By
09/02/22
CE